Roche Holding AG (LON: 0TDF)

Market Cap	196.85B
Revenue (ttm)	53.35B
Net Income (ttm)	9.35B
Shares Out	n/a
EPS (ttm)	11.66
PE Ratio	21.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Mar 14, 2024

Volume	250
Average Volume	252
Open	36.38
Previous Close	36.52
Day's Range	36.38 - 36.38
52-Week Range	29.35 - 41.85
Beta	n/a
RSI	51.03
Earnings Date	Jan 31, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, d...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,605
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0TDF

Financial Performance

In 2023, Roche Holding AG's revenue was 60.44 billion, a decrease of -8.16% compared to the previous year's 65.81 billion. Earnings were 11.50 billion, a decrease of -7.43%.

Financial numbers in CHF